Swedencare AB (publ) Share Price Nasdaq Stockholm
Equities
SE0008294078
Pharmaceuticals
Sales 2024 * | 2.66B 249M 20.71B | Sales 2025 * | 3B 281M 23.36B | Capitalization | 8.88B 833M 69.16B |
---|---|---|---|---|---|
Net income 2024 * | 228M 21.38M 1.78B | Net income 2025 * | 343M 32.17M 2.67B | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 1B 93.82M 7.79B | Net Debt 2025 * | 488M 45.76M 3.8B | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
39
x | P/E ratio 2025 * |
25.9
x | Employees | - |
Yield 2024 * |
0.89% | Yield 2025 * |
1.43% | Free-Float | 30.45% |
Latest transcript on Swedencare AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/14/01 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 01/23/01 | |
Director/Board Member | 57 | 01/16/01 | |
Director/Board Member | 61 | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
-13.83% | 77.6B | |
+24.00% | 3.67B | |
+0.14% | 3.27B | |
+14.70% | 1.67B | |
-4.46% | 1.59B | |
+2.54% | 1.35B | |
-22.01% | 1.3B | |
-12.12% | 1.15B | |
+1.55% | 1.09B |